Letters
Polymyalgia rheumatica
Fluorodeoxyglucose positron emission tomography/computed tomography: a “one stop shop” for diagnosing polymyalgia rheumatica
BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.f7705 (Published 06 January 2014) Cite this as: BMJ 2014;348:f7705- Michael S Hofman, physician in nuclear medicine and molecular imaging1
- 1Peter MacCallum Cancer Centre, East Melbourne, VIC 3002, Australia
- michael.hofman{at}petermac.org
In their clinical review Mackie and Mallen highlight that the diagnosis of polymyalgia rheumatica can be challenging and dependent on clinical experience and expertise, underscoring the need for better diagnostic algorithms.1 Given the various differential diagnoses, including occult infection, cancer, and myositis, patients are often subjected to an array of investigations before the diagnosis is established (often by exclusion), resulting in delayed diagnosis and costs associated …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.